Gore v. Medtronic stent graft patent suit thrown out; Covidien rolls out new respiratory monitor;

 @FierceMedDev: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @FierceMedDev

 @MarkHFierce: EndoGastric pulled in another $13M in new venture finding for a device designed to help treat chronic acid reflux. Press release | Follow @MarkHFierce

 @DamianFierce: Lawmakers, device industry on the same page as FDA user fee clears House, moves toward adoption. Article | Follow @DamianFierce

> A U.S. District Court judge threw out a 2010 lawsuit that accused Medtronic ($MDT) of violating W.L. Gore-held patents regarding the manufacturing of stent grafts. Story

> Covidien ($COV) is launching the Nellcor SpO2 respiratory monitor, designed to work with Philips Healthcare's IntelliVue patient monitoring platform. News

> Kansas company Post-T-Vac may have run up as much as $4.2 million in potentially bogus Medicare claims for the company's penis pumps, the Department of Health and Human Services inspector general alleges. Story

> Bio-Light Israeli Life Sciences Investments will acquire an ocular implant from a U.S. company that enables the sustained release of drugs to treat glaucoma. Story

> ReShape Medical has appointed former Allergan and Bausch + Lomb executive Robert E. Grant to its board of directors. The company is developing a non-surgical weight loss device. Release

Biotech News

 @FierceBiotech: See the faces of biotech leaders at BIO2012 in our convention slideshow. Slideshow | Follow @FierceBiotech

 @JohnCFierce: Interesting to note that if the ACA is tossed out by the Supremes, there goes 12 years of exclusivity for biologics and biosimilars pathway. Poof. | Follow @JohnCFierce

 @RyanMFierce: My take from BIO 2012 on how the pharma herd faces hurdles with pricey new drugs. Report | Follow @RyanMFierce

> Pozen shares slide after FDA questions study for aspirin combo. More

> House rushes through approval of new PDUFA legislation. News

> Onyx clears big hurdle in high-stakes gamble on early carfilzomib approval. Article

> FDA panel turns thumbs down on Sanofi's anti-clotting drug. Story

Pharma News

 @FiercePharma: AstraZeneca's Brilinta = lower healthcare costs, even at brand prices, finds cost-based analysis of PLATO data. More | Follow @FiercePharma

> Celgene's hopes for Revlimid stymied by regulatory setback. Story

> J&J close to $1.5B-plus Risperdal settlement, but not there yet. Article

> Is Madagascar 3's friendly lion a dangerous drug spokesman? More

> Anti-overtime ruling a disguised blessing for reps, recruiters say. Report

Pharma Manufacturing News

> Shasun cutting costs with Indian intermediates plant. Article

> Bard, Sartorius invest nearly $70M in Puerto Rico plants. Story

> CSL confirms convulsions appear tied to Fluvax manufacturing. More

Vaccines News

> HPV DNA vax should enter the clinic in 2013. More

> Therapeutic cancer vaccines: Optimism for the future at BIO2012. Article

> Anthrax vax to move into new Phase II trials. Story

> Genocea's HSV-2 vax to hit the clinic. News

CRO News

 @NesaNFierce: Not shocked that the Philippines and Indonesia are eyed as emerging leaders in outsourcing. Population means a lot. More | Follow @NesaNFierce

> Can Russia emerge as a global biotech and manufacturing leader? More

> Filling services help Dalton seal manufacturing deal with Clarity. Article

> Biopharma looks at pros and cons of CMOs when debating in-house versus outsourcing. News

And Finally... Aneuclose, a Minnesota device startup, is developing a mesh device (combined with microsponges) for use as a treatment of narrow-neck aneurysms. Story

Suggested Articles

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.

CMR Surgical will have a new CEO at the top of the year, as it kicks off the global launch of its modular Versius system while awaiting FDA approval.

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.